Cytori Therapeutics announces initiation of cell therapy heart failure trial Equities.com "Patients with refractory heart failure have no options except for heart transplant, for which there are few hearts available," said Dr Timothy Henry, director of research, at the Minneapolis Heart Institute Foundation. "Cell therapy such as Cytori's ... |